BlackRock Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

BlackRock Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$74K	Hold	15,097	–	–	﹤0.01%	3149
2016 Q3	$117K	Buy	15,097 +2,881	+24%	+$19.4K	﹤0.01%	2958
2016 Q2	$68K	Hold	12,216	–	–	﹤0.01%	3138
2016 Q1	$66K	Buy	12,216 +998	+9%	+$5.8K	﹤0.01%	3090
2015 Q4	$98K	Sell	11,218 -6,401	-36%	-$54K	﹤0.01%	2927
2015 Q3	$148K	Sell	17,619 -52,917	-75%	-$843K	﹤0.01%	2897
2015 Q2	$1.24M	Buy	70,536 +14,359	+26%	+$184K	﹤0.01%	1524
2015 Q1	$649K	Sell	56,177 -1,045	-2%	-$12.1K	﹤0.01%	1884
2014 Q4	$576K	Buy	57,222 +54,711	+2,179%	+$277K	﹤0.01%	1897
2014 Q3	$11K	Hold	2,511	–	–	﹤0.01%	3576
2014 Q2	$17K	Buy	+2,511	New	+$18.9K	﹤0.01%	3492

Other funds holding SRNE

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Advisors's SRNE Position: Q4 2016 in Review

BlackRock Advisors held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q4 2016 at 15,097 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #3149.

BlackRock Advisors first reported a position in SRNE in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.24M in Q2 2015. 68 funds tracked by Wall St. Rank hold SRNE as of Q4 2016.

BlackRock Advisors held 15,097 shares of Sorrento Therapeutics, Inc. worth $74K as of Q4 2016.
BlackRock Advisors left its Sorrento Therapeutics, Inc. share count unchanged in Q4 2016.
Sorrento Therapeutics, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3149 holding.
BlackRock Advisors first reported a position in Sorrento Therapeutics, Inc. in Q2 2014 and has held it in 11 quarters since.
BlackRock Advisors's Sorrento Therapeutics, Inc. position peaked at $1.24M in Q2 2015.
68 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.